Colgate-Palmolive Stock Price, News & Analysis (NYSE:CL)

$71.46 +0.24 (+0.34 %)
(As of 02/18/2018 03:37 AM ET)
Previous Close$71.46
Today's Range$70.81 - $71.84
52-Week Range$68.19 - $77.91
Volume4.42 million shs
Average Volume4.43 million shs
Market Capitalization$62.75 billion
P/E Ratio27.59
Dividend Yield2.24%

About Colgate-Palmolive (NYSE:CL)

Colgate-Palmolive logoColgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia. The Company's oral care products include Colgate Total, Colgate Sensitive Pro-Relief, Colgate Max Fresh and Colgate Optic White. The Company is also engaged in various product categories of the personal care market with operations in liquid hand soap, which it sells under the Palmolive, Protex and Softsoap brands. The Company manufactures and markets a range of products for the home care market, including Palmolive and Ajax dishwashing liquids, Fabuloso and Ajax household cleaners and Murphy's Oil Soap. The Company, through its Hill's Pet Nutrition segment (Hill's), manufactures pet nutrition products for dogs and cats.

Receive CL News and Ratings via Email

Sign-up to receive the latest news and ratings for CL and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Personal Products
Sub-IndustryHousehold Products
SectorNon-Cyclical Consumer Goods & Services


Debt-to-Equity Ratio24.42%
Current Ratio0.47%
Quick Ratio0.34%


Trailing P/E Ratio27.5907335907336
Forward P/E Ratio22.47
P/E Growth2.64

Sales & Book Value

Annual Sales$15.45 billion
Price / Sales4.05
Cash Flow$3.45 per share
Price / Cash20.71
Book Value$0.28 per share
Price / Book255.21


Trailing EPS$2.59
Net Income$2.02 billion
Net Margins13.10%
Return on Equity1,716.69%
Return on Assets20.17%


Outstanding Shares875,330,000

Colgate-Palmolive (NYSE:CL) Frequently Asked Questions

What is Colgate-Palmolive's stock symbol?

Colgate-Palmolive trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."

How often does Colgate-Palmolive pay dividends? What is the dividend yield for Colgate-Palmolive?

Colgate-Palmolive announced a quarterly dividend on Thursday, January 11th. Shareholders of record on Tuesday, January 23rd will be paid a dividend of $0.40 per share on Thursday, February 15th. This represents a $1.60 dividend on an annualized basis and a yield of 2.24%. The ex-dividend date is Monday, January 22nd. View Colgate-Palmolive's Dividend History.

How were Colgate-Palmolive's earnings last quarter?

Colgate-Palmolive (NYSE:CL) issued its quarterly earnings results on Friday, January, 26th. The company reported $0.75 earnings per share for the quarter, meeting the consensus estimate of $0.75. The firm earned $3.89 billion during the quarter, compared to analysts' expectations of $3.92 billion. Colgate-Palmolive had a net margin of 13.10% and a return on equity of 1,716.69%. Colgate-Palmolive's revenue was up 4.6% compared to the same quarter last year. During the same period in the prior year, the company earned $0.75 EPS. View Colgate-Palmolive's Earnings History.

When will Colgate-Palmolive make its next earnings announcement?

Colgate-Palmolive is scheduled to release their next quarterly earnings announcement on Friday, April, 27th 2018. View Earnings Estimates for Colgate-Palmolive.

Where is Colgate-Palmolive's stock going? Where will Colgate-Palmolive's stock price be in 2018?

15 Wall Street analysts have issued 1 year target prices for Colgate-Palmolive's stock. Their predictions range from $66.00 to $85.00. On average, they expect Colgate-Palmolive's share price to reach $77.33 in the next twelve months. View Analyst Ratings for Colgate-Palmolive.

What are Wall Street analysts saying about Colgate-Palmolive stock?

Here are some recent quotes from research analysts about Colgate-Palmolive stock:

  • 1. Jefferies Group LLC analysts commented, "CL’s 4Q print was disappointing w/org sales of +2% (vs. +3.4% Street) and GM%/OI below expectations. 4Q EPS of $0.75 was in-line with revs/GM% miss partially offset by lower SG&A and $0.02 from taxes. FY18 guide implies tepid low-to-mid single digit % underlying EPS growth (ex-Tax Act/FX benefits), which should augment HPC group GM % worries w/higher commodity costs, constrained pricing, and need for higher investment. We expect CL’s shares to trade down." (1/26/2018)
  • 2. According to Zacks Investment Research, "Colgate has outperformed the industry in the past month. The company is encouraged by the progress on the Global Growth and Efficiency Program along with additional savings anticipated from the recent expansion of the program. Moreover, the company has been infamous among investors with its meet or beat earnings track record. Though it posted in-line earnings and topped sales estimates in third-quarter 2017, margins remained strained due to increased raw material and packaging costs, as well as higher advertising expenses. Further, it anticipates these costs to persist and impact margins in 2017. The company also perked up its costs guidance related to charges arising from the expansion and extension of the Global Growth and Efficiency Program through Dec 31, 2019. Nonetheless, Colgate’s shareholder-friendly moves remain noteworthy. Estimates have been stable lately ahead of the fourth quarter earnings release." (1/16/2018)

Who are some of Colgate-Palmolive's key competitors?

Who are Colgate-Palmolive's key executives?

Colgate-Palmolive's management team includes the folowing people:

  • Ian M. Cook, Chairman of the Board, President, Chief Executive Officer (Age 64)
  • Daniel B. Marsili, Chief Human Resource Officer (Age 56)
  • John J. Huston, Senior Vice President - Chief of Staff (Age 62)
  • Patricia Verduin Ph.D., Chief Technology Officer (Age 58)
  • Mukul V. Deoras, Chief Marketing Officer (Age 53)
  • Henning I. Jakobsen, Vice President, Corporate Controller (Age 57)
  • Victoria L. Dolan, Chief Transformation Officer (Age 57)
  • Delia H. Thompson, Chief Investor Relations Officer (Age 67)
  • Makarand Karnataki, Company Secretary and Compliance Officer
  • Jennifer M. Daniels, Chief Legal Officer and Secretary (Age 53)

Who owns Colgate-Palmolive stock?

Colgate-Palmolive's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (5.96%), Bank of New York Mellon Corp (2.02%), Geode Capital Management LLC (1.02%), Renaissance Technologies LLC (0.98%), OppenheimerFunds Inc. (0.70%) and APG Asset Management N.V. (0.62%). Company insiders that own Colgate-Palmolive stock include Daniel B Marsili, Delia H Thompson, Dennis J Hickey, Ellen M Hancock, Franck J Moison, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin, Richard J Kogan, Stephen I Sadove and Victoria L Dolan. View Institutional Ownership Trends for Colgate-Palmolive.

Who sold Colgate-Palmolive stock? Who is selling Colgate-Palmolive stock?

Colgate-Palmolive's stock was sold by a variety of institutional investors in the last quarter, including Arrowstreet Capital Limited Partnership, Renaissance Technologies LLC, Credit Agricole S A, Standard Life Aberdeen plc, Congress Asset Management Co. MA, Capital Fund Management S.A., Metropolitan Life Insurance Co. NY and British Airways Pensions Investment Management Ltd. Company insiders that have sold Colgate-Palmolive company stock in the last year include Daniel B Marsili, Dennis J Hickey, Ellen M Hancock, Franck J Moison, Henning I Jakobsen, Jennifer Daniels, John J Huston, John T Cahill, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin, Richard J Kogan, Stephen I Sadove and Victoria L Dolan. View Insider Buying and Selling for Colgate-Palmolive.

Who bought Colgate-Palmolive stock? Who is buying Colgate-Palmolive stock?

Colgate-Palmolive's stock was bought by a variety of institutional investors in the last quarter, including Amundi Pioneer Asset Management Inc., APG Asset Management N.V., UBS Asset Management Americas Inc., VGI PARTNERS PTY Ltd, Schroder Investment Management Group, BlackRock Inc., Nuance Investments LLC and Fisher Asset Management LLC. View Insider Buying and Selling for Colgate-Palmolive.

How do I buy Colgate-Palmolive stock?

Shares of Colgate-Palmolive can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Colgate-Palmolive's stock price today?

One share of Colgate-Palmolive stock can currently be purchased for approximately $71.46.

How big of a company is Colgate-Palmolive?

Colgate-Palmolive has a market capitalization of $62.75 billion and generates $15.45 billion in revenue each year. The company earns $2.02 billion in net income (profit) each year or $2.59 on an earnings per share basis. Colgate-Palmolive employs 36,700 workers across the globe.

How can I contact Colgate-Palmolive?

Colgate-Palmolive's mailing address is 300 PARK AVE, NEW YORK, NY 10022-7402, United States. The company can be reached via phone at +1-212-3102000 or via email at [email protected]

MarketBeat Community Rating for Colgate-Palmolive (CL)

Community Ranking:  1.4 out of 5 (star)
Outperform Votes:  268 (Vote Outperform)
Underperform Votes:  664 (Vote Underperform)
Total Votes:  932
MarketBeat's community ratings are surveys of what our community members think about Colgate-Palmolive and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Colgate-Palmolive (NYSE:CL) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score:
Ratings Breakdown: 2 Sell Rating(s)
9 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
11 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
12 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
10 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $77.33$75.86$76.23$74.80
Price Target Upside: 5.19% upside2.52% upside8.21% upside2.09% upside

Colgate-Palmolive (NYSE:CL) Consensus Price Target History

Price Target History for Colgate-Palmolive (NYSE:CL)

Colgate-Palmolive (NYSE:CL) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/30/2018CitigroupBoost Price TargetNeutral -> Neutral$75.00 -> $80.00MediumView Rating Details
1/30/2018BNP ParibasDowngradeOutperform -> UnderperformMediumView Rating Details
1/26/2018Jefferies GroupReiterated RatingHold$79.00MediumView Rating Details
12/19/2017MacquarieUpgradeNeutral -> Outperform$81.00LowView Rating Details
12/13/2017Deutsche BankInitiated CoverageHold$75.00LowView Rating Details
11/29/2017Societe GeneraleDowngradeHold -> Sell$66.00MediumView Rating Details
11/25/2017KeyCorpReiterated RatingHoldLowView Rating Details
10/31/2017Morgan StanleyLower Price TargetOverweight$84.00 -> $83.00N/AView Rating Details
10/29/2017Stifel NicolausSet Price TargetHold$73.00N/AView Rating Details
10/11/2017SunTrust BanksUpgradeHold -> Buy$65.00 -> $85.00N/AView Rating Details
10/8/2017Royal Bank of CanadaReiterated RatingHold$74.00N/AView Rating Details
7/24/2017Wells Fargo & CoReiterated RatingMarket PerformLowView Rating Details
5/31/2017Bank of AmericaBoost Price TargetBuy$78.00 -> $80.00LowView Rating Details
3/21/2017JPMorgan Chase & Co.Initiated CoverageNeutral -> Neutral$77.00LowView Rating Details
2/18/2017BarclaysSet Price TargetHold$75.00N/AView Rating Details
2/3/2017B. RileyReiterated RatingNeutral$74.00N/AView Rating Details
1/25/2017Berenberg BankInitiated CoverageHold$68.00N/AView Rating Details
7/29/2016Exane BNP ParibasDowngradeOutperform -> NeutralN/AView Rating Details
7/15/2016Goldman Sachs GroupReiterated RatingNeutral$74.00 -> $76.00N/AView Rating Details
6/1/2016Atlantic SecuritiesInitiated CoverageOverweightN/AView Rating Details
2/26/2016Sterne Agee CRTDowngradeBuy -> NeutralN/AView Rating Details
(Data available from 2/18/2016 forward)


Colgate-Palmolive (NYSE:CL) Earnings History and Estimates Chart

Earnings by Quarter for Colgate-Palmolive (NYSE:CL)

Colgate-Palmolive (NYSE CL) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/26/2018$0.73N/AView Earnings Details
1/26/2018Q4 2017$0.75$0.75$3.92 billion$3.89 billionViewListenView Earnings Details
10/27/2017Q3 2017$0.73$0.73$3.94 billion$3.97 billionViewN/AView Earnings Details
7/21/2017Q2 2017$0.72$0.72$3.89 billion$3.83 billionViewN/AView Earnings Details
4/28/2017Q1 17$0.66$0.67$3.80 billion$3.76 billionViewN/AView Earnings Details
1/27/2017Q416$0.75$0.75$3.87 billion$3.72 billionViewN/AView Earnings Details
10/27/2016Q316$0.73$0.73$3.94 billion$3.87 billionViewListenView Earnings Details
7/28/2016Q216$0.69$0.70$3.86 billion$3.85 billionViewListenView Earnings Details
4/28/2016Q116$0.63$0.63$3.76 billion$3.76 billionViewListenView Earnings Details
1/29/2016Q415$0.72$0.73$3.94 billion$3.90 billionViewListenView Earnings Details
10/30/2015Q315$0.72$0.72$4.08 billion$4.00 billionViewListenView Earnings Details
7/30/2015Q215$0.70$0.70$4.07 billion$4.07 billionViewListenView Earnings Details
4/30/2015Q115$0.66$0.66$4.06 billion$4.07 billionViewN/AView Earnings Details
1/29/2015Q414$0.75$0.76$4.24 billion$4.22 billionViewN/AView Earnings Details
10/24/2014Q314$0.75$0.76$4.44 billion$4.38 billionViewListenView Earnings Details
7/31/2014Q214$0.73$0.73$4.41 billion$4.35 billionViewN/AView Earnings Details
4/25/2014Q114$0.68$0.68$4.32 billion$4.33 billionViewN/AView Earnings Details
1/31/2014Q413$0.74$0.75$4.40 billion$4.36 billionViewN/AView Earnings Details
10/24/2013Q313$0.73$0.73$4.46 billion$4.40 billionViewN/AView Earnings Details
7/25/2013Q2 2013$0.70$0.70$4.39 billion$4.35 billionViewN/AView Earnings Details
4/25/2013Q1 2013$1.32$1.32$4.30 billion$4.32 billionViewN/AView Earnings Details
1/31/2013Q4 2012$1.40$1.41$4.31 billion$4.29 billionViewN/AView Earnings Details
10/25/2012$1.39$1.38ViewN/AView Earnings Details
7/26/2012$1.33$1.33ViewN/AView Earnings Details
4/26/2012$1.24$1.24ViewN/AView Earnings Details
1/26/2012$1.30$1.30ViewN/AView Earnings Details
10/27/2011$1.30$1.31ViewN/AView Earnings Details
7/28/2011$1.25$1.26ViewN/AView Earnings Details
4/28/2011$1.16$1.16ViewN/AView Earnings Details
1/27/2011$1.23$1.24ViewN/AView Earnings Details
10/28/2010Q3 2010$0.60$0.61ViewN/AView Earnings Details
7/29/2010Q2 2010$0.58$0.59ViewN/AView Earnings Details
4/29/2010Q1 2010$0.58$0.61ViewN/AView Earnings Details
1/28/2010Q4 2009$0.59$0.60ViewN/AView Earnings Details
10/29/2009Q3 2009$0.56$0.56ViewN/AView Earnings Details
7/30/2009Q2 2009$0.52$0.54ViewN/AView Earnings Details
4/30/2009Q1 2009$0.49$0.48ViewN/AView Earnings Details
1/29/2009Q4 2008$0.49$0.50ViewN/AView Earnings Details
10/30/2008Q3 2008$0.49$0.50ViewN/AView Earnings Details
7/29/2008Q2 2008$0.47$0.49ViewN/AView Earnings Details
4/30/2008Q1 2008$0.44$0.45ViewN/AView Earnings Details
1/31/2008Q4 2007$0.45$0.45ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Colgate-Palmolive (NYSE:CL) Earnings Estimates

2018 EPS Consensus Estimate: $3.15
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.77$0.77$0.77
Q2 20181$0.76$0.76$0.76
Q3 20182$0.76$0.81$0.79
Q4 20182$0.82$0.84$0.83
(Earnings estimates data provided by Zacks Investment Research)


Colgate-Palmolive (NYSE:CL) Dividend Information

Most Recent Dividend:2/15/2018
Annual Dividend:$1.60
Dividend Yield:2.24%
Dividend Growth:3.80% (3 Year Average)
Payout Ratio:61.78% (Trailing 12 Months of Earnings)
50.31% (Based on This Year's Estimates)
46.51% (Based on Next Year's Estimates)
Track Record:54 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Colgate-Palmolive (NYSE:CL)

Colgate-Palmolive (NYSE:CL) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Colgate-Palmolive (NYSE CL) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.02%
Institutional Ownership Percentage: 72.85%
Insider Trades by Quarter for Colgate-Palmolive (NYSE:CL)
Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Colgate-Palmolive (NYSE CL) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/13/2018Franck J MoisonVice ChairmanSell44,418$69.87$3,103,485.66211,048View SEC Filing  
2/13/2018John T CahillDirectorSell7,000$69.96$489,720.00View SEC Filing  
2/12/2018Mukul DeorasInsiderSell7,150$70.03$500,714.50View SEC Filing  
2/9/2018Franck J MoisonVice ChairmanSell30,000$69.70$2,091,000.00211,048View SEC Filing  
2/9/2018John J HustonSVPSell14,000$69.44$972,160.00100,508View SEC Filing  
2/6/2018Franck J MoisonVice ChairmanSell142,979$70.09$10,021,398.11224,027View SEC Filing  
2/5/2018Henning I JakobsenVPSell36,215$71.22$2,579,232.3070,783View SEC Filing  
1/31/2018Ellen M HancockDirectorSell4,676$74.12$346,585.12208,063View SEC Filing  
1/31/2018Noel R WallaceCOOSell126,304$73.78$9,318,709.12305,631View SEC Filing  
1/9/2018Jennifer DanielsInsiderSell902$75.82$68,389.6437,788View SEC Filing  
12/13/2017Jennifer DanielsInsiderSell7,375$73.18$539,702.5038,691View SEC Filing  
11/14/2017Victoria L DolanInsiderSell9,000$73.41$660,690.00View SEC Filing  
11/10/2017Mukul DeorasCMOSell7,500$73.28$549,600.0045,217View SEC Filing  
11/9/2017Justin SkalaCOOSell126,393$72.97$9,222,897.21262,361View SEC Filing  
11/9/2017Victoria L DolanInsiderSell10,000$73.07$730,700.0060,528View SEC Filing  
11/6/2017Stephen I SadoveDirectorSell20,780$70.52$1,465,405.6036,268View SEC Filing  
8/15/2017Patricia VerduinInsiderSell3,833$71.45$273,867.8553,173View SEC Filing  
8/10/2017John J HustonSVPSell14,000$71.36$999,040.0088,598View SEC Filing  
8/7/2017Franck J MoisonVice ChairmanSell35,000$71.52$2,503,200.00201,411View SEC Filing  
8/3/2017Dennis J HickeyCFOSell73,872$71.80$5,304,009.60484,985View SEC Filing  
8/1/2017Ellen M HancockDirectorSell5,057$71.91$363,648.87199,777View SEC Filing  
7/27/2017John T CahillDirectorSell8,000$72.47$579,760.0031,786View SEC Filing  
7/27/2017Justin SkalaCOOSell74,374$72.51$5,392,858.7497,177View SEC Filing  
7/17/2017Patricia VerduinInsiderSell3,833$72.41$277,547.5353,022View SEC Filing  
6/15/2017Patricia VerduinInsiderSell3,833$75.67$290,043.1153,022View SEC Filing  
5/10/2017John J HustonSVPSell14,000$71.53$1,001,420.00102,838View SEC Filing  
5/8/2017Richard J KoganDirectorSell8,000$71.92$575,360.0073,065View SEC Filing  
4/17/2017Daniel B MarsiliVPSell14,000$73.97$1,035,580.0073,904View SEC Filing  
4/17/2017Patricia VerduinInsiderSell3,833$73.72$282,568.7653,022View SEC Filing  
2/3/2017Stephen I SadoveDirectorSell8,000$66.00$528,000.0033,761View SEC Filing  
1/17/2017Patricia VerduinInsiderSell3,833$65.99$252,939.6754,924View SEC Filing  
1/9/2017Jennifer DanielsInsiderSell868$66.62$57,826.1636,813View SEC Filing  
12/15/2016Patricia VerduinInsiderSell3,834$65.66$251,740.4454,791View SEC Filing  
12/13/2016Jennifer DanielsInsiderSell7,072$66.78$472,268.1637,463View SEC Filing  
10/17/2016Patricia VerduinInsiderSell3,834$72.39$277,543.2655,013View SEC Filing  
9/15/2016Patricia VerduinInsiderSell3,834$71.85$275,472.9055,013View SEC Filing  
8/11/2016Franck J MoisonCOOSell15,000$75.16$1,127,400.00188,029View SEC Filing  
8/10/2016John J HustonSVPSell14,000$74.93$1,049,020.00102,761View SEC Filing  
8/10/2016Richard J KoganDirectorSell8,000$74.66$597,280.0076,065View SEC Filing  
8/8/2016Stephen I SadoveDirectorSell8,803$74.28$653,886.8426,474View SEC Filing  
8/2/2016Ellen M HancockDirectorSell4,584$74.82$342,974.88203,632View SEC Filing  
8/2/2016Noel R WallaceCOOSell78,849$74.69$5,889,231.81236,295View SEC Filing  
7/15/2016Patricia VerduinCTOSell3,666$74.98$274,876.6854,602View SEC Filing  
6/15/2016Patricia VerduinCTOSell3,666$72.19$264,648.5454,602View SEC Filing  
5/16/2016Patricia VerduinCTOSell3,666$71.59$262,448.9454,602View SEC Filing  
5/11/2016Ellen M HancockDirectorSell4,566$71.85$328,067.10199,742View SEC Filing  
5/11/2016John J HustonVPSell14,000$72.23$1,011,220.00101,843View SEC Filing  
5/11/2016Justin SkalaCOOSell89,200$72.17$6,437,564.0097,338View SEC Filing  
5/9/2016Noel R WallaceCOOSell8,931$72.06$643,567.86155,822View SEC Filing  
5/5/2016Delia H ThompsonVPSell40,000$72.08$2,883,200.00187,673View SEC Filing  
5/3/2016John T CahillDirectorSell16,000$72.30$1,156,800.0028,696View SEC Filing  
5/3/2016Noel R WallaceCOOSell60,000$72.16$4,329,600.00204,270View SEC Filing  
5/3/2016Victoria L DolanVPSell19,334$71.76$1,387,407.8455,526View SEC Filing  
4/15/2016Patricia VerduinCTOSell3,666$70.83$259,662.7854,602View SEC Filing  
3/8/2016Delia H ThompsonVPSell1,698$67.36$114,377.28147,673View SEC Filing  
3/8/2016Dennis J HickeyCFOSell5,420$67.36$365,091.20387,284View SEC Filing  
3/8/2016Franck J MoisonCOOSell6,661$67.36$448,684.96172,841View SEC Filing  
3/8/2016Ian M CookCEOSell25,238$67.36$1,700,031.681,281,800View SEC Filing  
3/8/2016Mukul DeorasCMOSell1,325$67.36$89,252.0046,866View SEC Filing  
3/8/2016Noel R WallaceInsiderSell5,238$67.36$352,831.68126,622View SEC Filing  
3/8/2016Patricia VerduinCTOSell1,953$67.36$131,554.0850,936View SEC Filing  
2/17/2016Dennis J. HickeyCFOSell50,697$67.05$3,399,233.85392,493View SEC Filing  
2/16/2016Fabian T. GarciaCOOSell145,000$65.72$9,529,400.00117,517View SEC Filing  
2/16/2016Patricia VerduinCTOSell3,666$66.58$244,082.2848,068View SEC Filing  
2/11/2016John J. HustonVPSell14,000$64.89$908,460.0086,438View SEC Filing  
2/10/2016Richard J. KoganDirectorSell8,000$66.27$530,160.0068,557View SEC Filing  
2/5/2016Delano E LewisDirectorSell200$65.92$13,184.0017,920View SEC Filing  
1/15/2016Patricia VerduinCTOSell3,666$62.37$228,648.4248,068View SEC Filing  
1/11/2016Jennifer DanielsInsiderSell837$62.85$52,605.4536,938View SEC Filing  
8/14/2015Ellen M HancockDirectorSell3,637$67.89$246,915.93View SEC Filing  
6/15/2015Daniel B MarsiliVPSell14,000$65.65$919,100.00View SEC Filing  
6/15/2015Patricia VerduinCTOSell3,333$65.64$218,778.12View SEC Filing  
5/15/2015Delano E LewisDirectorSell6,023$68.51$412,635.73View SEC Filing  
4/15/2015Daniel B MarsiliVPSell14,000$69.93$979,020.00View SEC Filing  
4/15/2015Patricia VerduinCTOSell3,333$69.89$232,943.37View SEC Filing  
3/9/2015Dennis J HickeyCFOSell18,224$69.49$1,266,385.76View SEC Filing  
3/9/2015Fabian T GarciaCOOSell10,137$69.49$704,420.13View SEC Filing  
3/9/2015Noel R WallaceInsiderSell6,638$69.49$461,274.62View SEC Filing  
3/9/2015Patricia VerduinCTOSell2,828$69.49$196,517.72View SEC Filing  
3/9/2015Victoria L DolanVPSell2,834$69.49$196,934.66View SEC Filing  
2/10/2015Ellen M HancockDirectorSell4,011$69.38$278,283.18View SEC Filing  
2/10/2015John J HustonVPSell14,000$69.19$968,660.00View SEC Filing  
2/5/2015Delano E LewisDirectorSell9,226$69.05$637,055.30View SEC Filing  
1/27/2015Andrew D HendryVice ChairmanSell10,000$65.29$652,900.00View SEC Filing  
1/15/2015Patricia VerduinCTOSell3,333$68.66$228,843.78View SEC Filing  
12/23/2014Andrew D HendryVice ChairmanSell10,000$70.39$703,900.00View SEC Filing  
12/15/2014Patricia VerduinCTOSell3,333$68.65$228,810.45View SEC Filing  
11/25/2014Andrew D HendryVice ChairmanSell10,000$67.94$679,400.00View SEC Filing  
11/25/2014Larisa HarrisonDirectorBuy2,000$0.29$570.00
11/17/2014Patricia VerduinCTOSell3,333$67.48$224,910.84View SEC Filing  
11/11/2014Andrew D HendryVice ChairmanSell10,000$68.46$684,600.00View SEC Filing  
10/29/2014Nigel BurtonCMOSell2,323$65.89$153,062.47View SEC Filing  
10/28/2014Andrew D HendryVice ChairmanSell10,000$66.32$663,200.00View SEC Filing  
9/23/2014Andrew D HendryVice ChairmanSell10,000$65.50$655,000.00View SEC Filing  
9/15/2014Patricia VerduinCTOSell3,337$64.27$214,468.99View SEC Filing  
9/9/2014Andrew D HendryVice ChairmanSell10,000$63.52$635,200.00View SEC Filing  
8/18/2014Delia H ThompsonVPSell40,000$64.75$2,590,000.00View SEC Filing  
8/18/2014Justin SkalaInsiderSell41,525$64.52$2,679,193.00View SEC Filing  
8/8/2014Franck J MoisonCOOSell24,888$64.73$1,611,000.24View SEC Filing  
8/5/2014Franck J MoisonCOOSell41,654$63.91$2,662,107.14View SEC Filing  
7/22/2014Andrew D HendryVice ChairmanSell10,000$68.73$687,300.00View SEC Filing  
7/15/2014Daniel B MarsiliVPSell15,500$69.71$1,080,505.00View SEC Filing  
7/10/2014Patricia VerduinCTOSell2,291$69.66$159,591.06View SEC Filing  
7/8/2014Andrew D HendryVice ChairmanSell10,000$68.64$686,400.00View SEC Filing  
6/24/2014Andrew D HendryVice ChairmanSell10,000$67.72$677,200.00View SEC Filing  
6/16/2014Daniel B MarsiliVPSell15,500$67.59$1,047,645.00View SEC Filing  
6/10/2014Andrew D HendryVice ChairmanSell6,000$68.57$411,420.00View SEC Filing  
5/27/2014Andrew D HendryVice ChairmanSell6,000$66.90$401,400.00View SEC Filing  
5/15/2014Patricia VerduinCTOSell2,000$66.86$133,720.0049,913View SEC Filing  
5/13/2014Andrew HendryVice ChairmanSell6,000$67.25$403,500.00185,726View SEC Filing  
5/13/2014Delano LewisDirectorSell2,100$67.19$141,099.0023,550View SEC Filing  
5/13/2014Dennis HickeyCFOSell51,352$67.18$3,449,827.36360,282View SEC Filing  
5/12/2014Daniel MarsiliVPSell15,500$67.37$1,044,235.0075,079View SEC Filing  
5/7/2014Stephen FogartyInsiderSell11,000$67.23$739,530.0023,809View SEC Filing  
5/2/2014Ronald MartinVPSell3,000$67.13$201,390.007,567View SEC Filing  
5/1/2014Delano LewisDirectorSell5,000$67.07$335,350.0023,642View SEC Filing  
5/1/2014Fabian GarciaCOOSell122,000$67.04$8,178,880.00193,936View SEC Filing  
4/22/2014Andrew HendryVice ChairmanSell6,000$66.89$401,340.00185,726View SEC Filing  
4/15/2014Patricia VerduinCTOSell2,000$66.09$132,180.0049,913View SEC Filing  
4/8/2014Andrew HendryVice ChairmanSell6,000$65.03$390,180.00185,726View SEC Filing  
3/17/2014Patricia VerduinCTOSell2,000$64.06$128,120.0049,913View SEC Filing  
2/28/2014Stephen FogartyInsiderSell12,000$63.10$757,200.0023,809View SEC Filing  
1/28/2014Andrew HendryVice ChairmanSell6,000$62.31$373,860.00192,093View SEC Filing  
12/24/2013Andrew HendryVice ChairmanSell6,000$64.80$388,800.00192,093View SEC Filing  
12/16/2013Patricia VerduinCTOSell2,000$64.14$128,280.0048,573View SEC Filing  
10/29/2013Michael CorboVPSell15,770$65.00$1,025,050.00View SEC Filing  
10/29/2013Nigel BurtonCMOSell19,862$65.51$1,301,159.62View SEC Filing  
10/29/2013Stephen J FogartyInsiderSell12,000$65.67$788,040.00View SEC Filing  
10/22/2013Andrew D HendryVice ChairmanSell6,000$62.40$374,400.00View SEC Filing  
10/15/2013Patricia VerduinCTOSell2,000$61.51$123,020.00View SEC Filing  
10/8/2013Andrew HendryVice ChairmanSell6,000$59.35$356,100.00192,547View SEC Filing  
9/24/2013Andrew HendryVice ChairmanSell6,000$60.00$360,000.00192,547View SEC Filing  
9/17/2013Michael CorboVPSell1,108$59.62$66,058.9625,177View SEC Filing  
9/17/2013Nigel BurtonCMOSell2,015$59.62$120,134.3045,139View SEC Filing  
9/17/2013Patricia VerduinCTOSell3,649$59.71$217,881.7948,414View SEC Filing  
9/17/2013Stephen FogartyInsiderSell1,035$59.62$61,706.7021,770View SEC Filing  
9/10/2013Andrew D HendryVice ChairmanSell6,000$58.79$352,740.00View SEC Filing  
8/15/2013Franck MoisonCOOSell12,400$60.28$747,472.00160,538View SEC Filing  
8/15/2013Guillenchmidt Alec DeInsiderSell3,888$60.28$234,368.6499,722View SEC Filing  
8/15/2013Patricia VerduinCTOSell2,000$60.28$120,560.0049,872View SEC Filing  
8/12/2013Delia ThompsonVPSell30,950$60.73$1,879,593.50146,551View SEC Filing  
8/12/2013Stephen FogartyInsiderSell12,000$60.64$727,680.0022,725View SEC Filing  
8/8/2013Nigel BurtonCMOSell18,667$61.06$1,139,807.0246,974View SEC Filing  
8/6/2013Elaine PaikVPSell7,141$60.94$435,172.5415,629View SEC Filing  
8/6/2013Mukul DeorasInsiderSell8,417$60.90$512,595.3030,058View SEC Filing  
7/31/2013Ronald T MartinVPSell1,800$60.27$108,486.00View SEC Filing  
7/30/2013Michael CorboVPSell10,000$60.21$602,100.00View SEC Filing  
7/15/2013Franck J MoisonCOOSell12,400$59.05$732,220.00View SEC Filing  
7/15/2013Justin SkalaInsiderSell4,822$59.03$284,642.66View SEC Filing  
7/15/2013Michael CorboVPSell2,000$59.13$118,260.00View SEC Filing  
6/17/2013Franck J MoisonCOOSell12,400$59.18$733,832.00View SEC Filing  
6/17/2013Guillenchmidt Alec DeInsiderSell3,888$59.09$229,741.92View SEC Filing  
6/17/2013Michael CorboVPSell2,000$59.09$118,180.00View SEC Filing  
6/4/2013Andrew D HendryVice ChairmanSell4,000$58.84$235,360.00View SEC Filing  
5/21/2013Andrew D HendryVice ChairmanSell6,000$61.63$369,780.00View SEC Filing  
5/15/2013Franck J MoisonCOOSell6,200$122.66$760,492.00View SEC Filing  
5/15/2013Guillenchmidt Alec DeInsiderSell1,944$122.66$238,451.04View SEC Filing  
5/15/2013Michael CorboVPSell1,000$122.66$122,660.00View SEC Filing  
5/13/2013Rosemary NelsonVPSell14,000$121.00$1,694,000.00View SEC Filing  
5/10/2013Dennis J HickeyCFOSell64,000$120.54$7,714,560.00View SEC Filing  
5/7/2013Andrew D HendryVice ChairmanSell6,000$120.37$722,220.00View SEC Filing  
4/30/2013Nigel BurtonCMOSell80,334$118.68$9,534,039.12View SEC Filing  
2/26/2013Daniel B MarsiliVPSell12,252$113.66$1,392,562.32View SEC Filing  
2/26/2013Justin SkalaInsiderSell5,894$113.64$669,794.16View SEC Filing  
12/4/2012Andrew D HendryVice ChairmanSell6,000$108.00$648,000.00View SEC Filing  
10/2/2012Andrew D HendryVice ChairmanSell6,000$108.27$649,620.00View SEC Filing  
9/4/2012Andrew D HendryVice ChairmanSell6,000$106.16$636,960.00View SEC Filing  
(Data available from 1/1/2013 forward)


Colgate-Palmolive (NYSE CL) News Headlines

Does Colgate-Palmolive Company’s (NYSE:CL) Past Performance Indicate A Weaker Future?Does Colgate-Palmolive Company’s (NYSE:CL) Past Performance Indicate A Weaker Future? - February 16 at 5:08 PM
[$$] How to read the regime change at the US Federal Reserve[$$] How to read the regime change at the US Federal Reserve - February 16 at 8:31 AM
Colgate-Palmolive (CL) Director John T. Cahill Sells 7,000 SharesColgate-Palmolive (CL) Director John T. Cahill Sells 7,000 Shares - February 15 at 9:26 PM
Colgate-Palmolive Co (CL) Files 10-K for the Fiscal Year Ended on December 31, 2017Colgate-Palmolive Co (CL) Files 10-K for the Fiscal Year Ended on December 31, 2017 - February 15 at 5:10 PM
By How Much Will Colgate-Palmolive Raise Its Dividend? - Seeking AlphaBy How Much Will Colgate-Palmolive Raise Its Dividend? - Seeking Alpha - February 15 at 8:03 AM
Insider Selling: Colgate-Palmolive (CL) Insider Sells 7,150 Shares of StockInsider Selling: Colgate-Palmolive (CL) Insider Sells 7,150 Shares of Stock - February 14 at 9:40 PM
Own Colgate-Palmolive At Your Own RiskOwn Colgate-Palmolive At Your Own Risk - February 14 at 5:19 PM
Colgate-Palmolive (CL) SVP John J. Huston Sells 14,000 SharesColgate-Palmolive (CL) SVP John J. Huston Sells 14,000 Shares - February 13 at 6:10 PM
Colgate-Palmolive (CL) Vice Chairman Sells $3,103,485.66 in StockColgate-Palmolive (CL) Vice Chairman Sells $3,103,485.66 in Stock - February 13 at 6:10 PM
Colgate-Palmolive (CL) Vice Chairman Sells $2,091,000.00 in StockColgate-Palmolive (CL) Vice Chairman Sells $2,091,000.00 in Stock - February 13 at 6:10 PM
Its A Numbers Game: Take Colgate Over Proctor And Kimberly ClarkIt's A Numbers Game: Take Colgate Over Proctor And Kimberly Clark - February 13 at 3:54 PM
Retirement Strategy: A Walk On The Wild SideRetirement Strategy: A Walk On The Wild Side - February 13 at 9:50 AM
Colgate-Palmolive Company: The No. 1 Reason To Buy Colgate StockColgate-Palmolive Company: The No. 1 Reason To Buy Colgate Stock - February 12 at 9:42 AM
Have Investors Already Priced In Colgate-Palmolive Company’s (NYSE:CL) Growth?Have Investors Already Priced In Colgate-Palmolive Company’s (NYSE:CL) Growth? - February 8 at 8:21 AM
Colgate-Palmolive (CL) Expected to Announce Quarterly Sales of $4.01 BillionColgate-Palmolive (CL) Expected to Announce Quarterly Sales of $4.01 Billion - February 8 at 6:52 AM
Colgate-Palmolive (CL) Vice Chairman Sells $10,021,398.11 in StockColgate-Palmolive (CL) Vice Chairman Sells $10,021,398.11 in Stock - February 8 at 12:10 AM
Insider Selling: Colgate-Palmolive (CL) VP Sells 36,215 Shares of StockInsider Selling: Colgate-Palmolive (CL) VP Sells 36,215 Shares of Stock - February 8 at 12:10 AM
Colgate-Palmolive Webcasts Presentation at The Consumer Analyst Group of New York ConferenceColgate-Palmolive Webcasts Presentation at The Consumer Analyst Group of New York Conference - February 7 at 9:51 AM
Colgate-Palmolive (CL) Receives Average Rating of "Hold" from BrokeragesColgate-Palmolive (CL) Receives Average Rating of "Hold" from Brokerages - February 6 at 5:24 PM
Why Clorox’s Fiscal 2Q18 Margins SlumpedWhy Clorox’s Fiscal 2Q18 Margins Slumped - February 6 at 9:41 AM
Free Post Earnings Research Report: Colgate-Palmolive’s Net Sales Grew 4.5%Free Post Earnings Research Report: Colgate-Palmolive’s Net Sales Grew 4.5% - February 6 at 9:41 AM
Colgate-Palmolive (CL) Expected to Announce Earnings of $0.74 Per ShareColgate-Palmolive (CL) Expected to Announce Earnings of $0.74 Per Share - February 6 at 5:10 AM
Insider Selling: Colgate-Palmolive (CL) Director Sells 4,676 Shares of StockInsider Selling: Colgate-Palmolive (CL) Director Sells 4,676 Shares of Stock - February 2 at 9:26 PM
Colgate-Palmolive (CL) COO Sells $9,318,709.12 in StockColgate-Palmolive (CL) COO Sells $9,318,709.12 in Stock - February 2 at 9:10 PM
Pick Up Colgate-Palmolive Company on This Dip - Investorplace.comPick Up Colgate-Palmolive Company on This Dip - - February 2 at 9:46 AM
Pick Up Colgate-Palmolive Company on This DipPick Up Colgate-Palmolive Company on This Dip - January 31 at 11:03 AM
Colgate-Palmolive (CL) Cut to "Underperform" at BNP ParibasColgate-Palmolive (CL) Cut to "Underperform" at BNP Paribas - January 30 at 10:16 PM
Colgate-Palmolive (CL) PT Raised to $80.00 at CitigroupColgate-Palmolive (CL) PT Raised to $80.00 at Citigroup - January 30 at 9:10 PM
Analyzing Colgate-Palmolive’s Regional Sales in 4Q17Analyzing Colgate-Palmolive’s Regional Sales in 4Q17 - January 30 at 10:21 AM
What Weighed on Colgate-Palmolive’s 4Q Profit Margins?What Weighed on Colgate-Palmolive’s 4Q Profit Margins? - January 30 at 10:21 AM
Interesting CL Put And Call Options For April 20thInteresting CL Put And Call Options For April 20th - January 29 at 3:53 PM
Key Takeaways From Colgate-Palmolives Q4 EarningsKey Takeaways From Colgate-Palmolive's Q4 Earnings - January 29 at 3:53 PM
Today’s Research Reports on Stocks to Watch: Starbucks and Colgate-Palmolive CompanyToday’s Research Reports on Stocks to Watch: Starbucks and Colgate-Palmolive Company - January 29 at 9:57 AM
Hate Risk? Youll Love These 3 StocksHate Risk? You'll Love These 3 Stocks - January 28 at 12:13 PM
Why Colgate-Palmolive Company Stock Dropped TodayWhy Colgate-Palmolive Company Stock Dropped Today - January 26 at 6:34 PM
Intel and AbbVie jump while Starbucks and Colgate skidIntel and AbbVie jump while Starbucks and Colgate skid - January 26 at 5:40 PM
Colgate-Palmolive Remains Firmly Negative In Afternoon TradingColgate-Palmolive Remains Firmly Negative In Afternoon Trading - January 26 at 3:53 PM
Colgate-Palmolive shares fall on sales, growth concernsColgate-Palmolive shares fall on sales, growth concerns - January 26 at 3:53 PM
Wall Street Bull After GDP NumbersWall Street Bull After GDP Numbers - January 26 at 3:53 PM
Colgate-Palmolive Company Stocks Sinks on Q4 EarningsColgate-Palmolive Company Stocks Sinks on Q4 Earnings - January 26 at 12:39 PM
Jefferies Group Reaffirms "Hold" Rating for Colgate-Palmolive (CL)Jefferies Group Reaffirms "Hold" Rating for Colgate-Palmolive (CL) - January 26 at 11:38 AM
Colgates Checkup Doesnt Go WellColgate's Checkup Doesn't Go Well - January 26 at 10:57 AM
Pricing nips at Colgate-Palmolives marginsPricing nips at Colgate-Palmolive's margins - January 26 at 9:55 AM
Colgate (CL) Stock Falls on Flat Q4 Earnings and Sales LagColgate (CL) Stock Falls on Flat Q4 Earnings and Sales Lag - January 26 at 9:55 AM
Colgate-Palmolive shares slide after concerns about challenging 2018Colgate-Palmolive shares slide after concerns about challenging 2018 - January 26 at 9:55 AM
Colgate-Palmolive meets 4Q profit forecastsColgate-Palmolive meets 4Q profit forecasts - January 26 at 9:55 AM
Colgates quarterly sales fall short of estimatesColgate's quarterly sales fall short of estimates - January 26 at 9:55 AM
Colgate-Palmolive (CL) Posts  Earnings Results, Hits ExpectationsColgate-Palmolive (CL) Posts Earnings Results, Hits Expectations - January 26 at 9:42 AM
What Analysts Suggest for Kimberly-Clark Stock after 4Q17What Analysts Suggest for Kimberly-Clark Stock after 4Q17 - January 25 at 3:54 PM
What To Expect From Colgate-Palmolives Q4 EarningsWhat To Expect From Colgate-Palmolive's Q4 Earnings - January 25 at 3:54 PM

SEC Filings

Colgate-Palmolive (NYSE:CL) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Colgate-Palmolive (NYSE:CL) Income Statement, Balance Sheet and Cash Flow Statement


Colgate-Palmolive (NYSE CL) Stock Chart for Sunday, February, 18, 2018

Loading chart…

This page was last updated on 2/18/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.